Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, Morris JC, Kleinberger G, Nellgard B, Vöglein J, Blennow K, Zetterberg H, Ewers M, Jucker M, Levin J, Bateman RJ, Haass C; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2022 Apr;21(4):329-341. doi: 10.1016/S1474-4422(22)00027-8.

Cerebrospinal Fluid Total Tau Protein Correlates With Longitudinal, Progressing Cognitive Dysfunction in Anti-Neural Autoantibody-Associated Dementia and Alzheimer's Dementia: A Case-Control Study

Hansen N, Juhl AL, Grenzer IM, Hirschel S, Teegen B, Fitzner D, Bartels C, Timäus C, Wiltfang J, Malchow B.

Front Immunol. 2022 Mar 3;13:837376. doi: 10.3389/fimmu.2022.837376. eCollection 2022.

Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

Saunders TS, Gadd DA, Spires-Jones TL, King D, Ritchie C, Muniz-Terrera G.

Eur J Neurosci. 2022 Nov;56(9):5650-5713. doi: 10.1111/ejn.15656. Epub 2022 May 12.

Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study

Wang T, Wang X, Yao Y, Zhao C, Yang C, Han Y, Cai Y.

BMJ Open. 2022 Apr 6;12(4):e054347. doi: 10.1136/bmjopen-2021-054347.

Effects of a staged integral art-based cognitive intervention (SIACI) program in older adults with cognitive impairments: protocol for a randomized controlled trial

Yan YJ, Ma MP, Cai WC, Huang CS, Lin R, Chen YF, Li H.

BMC Geriatr. 2022 Apr 7;22(1):296. doi: 10.1186/s12877-022-02961-4.

Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants

Mozersky J, Roberts JS, Rumbaugh M, Chhatwal J, Wijsman E, Galasko D, Blacker D; AGREED.

J Alzheimers Dis. 2022;90(3):1035-1043. doi: 10.3233/JAD-220113.

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Jessen F, Wolfsgruber S, Kleineindam L, Spottke A, Altenstein S, Bartels C, Berger M, Brosseron F, Daamen M, Dichgans M, Dobisch L, Ewers M, Fenski F, Fliessbach K, Freiesleben SD, Glanz W, Görß D, Gürsel S, Janowitz D, Kilimann I, Kobeleva X, Lohse A, Maier F, Metzger C, Munk M, Preis L, Sanzenbacher C, Spruth E, Rauchmann B, Vukovich R, Yakupov R, Weyrauch AS, Ziegler G, Schmid M, Laske C, Perneczky R, Schneider A, Wiltfang J, Teipel S, Bürger K, Priller J, Peters O, Ramirez A, Boecker H, Heneka MT, Wagner M, Düzel E.

Alzheimers Dement. 2023 Feb;19(2):487-497. doi: 10.1002/alz.12674. Epub 2022 Apr 22.

Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Botto R, Callai N, Cermelli A, Causarano L, Rainero I.

Neurol Sci. 2022 Jul;43(7):4107-4124. doi: 10.1007/s10072-022-06068-x. Epub 2022 Apr 23.

Amyloid-β protein and MicroRNA-384 in NCAM-Labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer's disease

Li Y, Meng S, Di W, Xia M, Dong L, Zhao Y, Ling S, He J, Xue X, Chen X, Liu C.

CNS Neurosci Ther. 2022 Jul;28(7):1093-1107. doi: 10.1111/cns.13846. Epub 2022 Apr 26.

Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis

Custodero C, Ciavarella A, Panza F, Gnocchi D, Lenato GM, Lee J, Mazzocca A, Sabbà C, Solfrizzi V.

Geroscience. 2022 Jun;44(3):1373-1392. doi: 10.1007/s11357-022-00556-w. Epub 2022 Apr 29.

Brain ventricles, CSF and cognition: a narrative review

de Mélo Silva Júnior ML, Diniz PRB, de Souza Vilanova MV, Basto GPT, Valença MM.

Psychogeriatrics. 2022 Jul;22(4):544-552. doi: 10.1111/psyg.12839. Epub 2022 Apr 30.

Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials

Ossenkoppele R, van der Kant R, Hansson O.

Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.

Effects of interventions on cerebral perfusion in the Alzheimer's disease spectrum: A systematic review

Marcolini S, Frentz I, Sanchez-Catasus CA, Mondragon JD, Feltes PK, van der Hoorn A, Borra RJH, Ikram MA, Dierckx RAJO, De Deyn PP.

Ageing Res Rev. 2022 Aug;79:101661. doi: 10.1016/j.arr.2022.101661. Epub 2022 Jun 4.

Alzheimer Disease

McDade EM.

Continuum (Minneap Minn). 2022 Jun 1;28(3):648-675. doi: 10.1212/CON.0000000000001131.

Atypical Alzheimer Disease Variants

Polsinelli AJ, Apostolova LG.

Continuum (Minneap Minn). 2022 Jun 1;28(3):676-701. doi: 10.1212/CON.0000000000001082.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias